Article Text

Download PDFPDF
Budesonide increased symptom free days in patients with recent onset mild asthma at an additional cost of US$0.42/day

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • * Data provided by author.


  • * See glossary.

  • Information provided by author.

  • For correspondence: Dr S D Sullivan, University of Washington, Seattle, WA, USA.

  • Source of funding: AstraZeneca Research and Development.

Linked Articles

  • Glossary
    BMJ Publishing Group Ltd